Results 61 to 70 of about 17,749 (253)

Trained Immunity and Cardiovascular Risk: An Immunological Perspective

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Systemic inflammation is a key driver of atherogenesis and its complications. While anti‐inflammatory therapies targeting pathways such as IL‐1β and IL‐6 have shown promise in established atherosclerotic cardiovascular disease (ASCVD), potential systemic effects raise concerns about immune suppression and infection, underscoring the need for ...
Katherine A. Boden   +3 more
wiley   +1 more source

Consensus hyperaldostéronisme primaire SFE/SFHTA/AFCE, groupe 6: Chirurgie surrénale [PDF]

open access: yes, 2016
International audienceTreatment of primary aldosteronism (PA) aims at preventing or correcting hypertension, hypokalemia and target organ damage. Patients with lateralized PA and candidates for surgery may be managed by laparoscopic adrenalectomy ...
Amar, Laurence   +5 more
core   +4 more sources

Screening and Diagnosis of Primary Aldosteronism in Patients Using Renin‐Angiotensin System Inhibitors

open access: yesThe Journal of Clinical Hypertension, Volume 28, Issue 1, January 2026.
ABSTRACT This study investigated whether patients receiving renin‐angiotensin system inhibitors (RASIs) can undergo reliable screening for primary aldosteronism (PA) without discontinuation of therapy. Consecutive patients with hypertension who underwent PA screening at our hospital between 2016 and 2024 while on RASIs were recruited.
Qian Wang   +4 more
wiley   +1 more source

How the algorithms can change during the COVID-19 pandemic: A case of primary hyperaldosteronism [PDF]

open access: diamond, 2023
Burçin Gönül İremli   +2 more
openalex   +1 more source

A case report of hyponatremia after surgery for Conn's adenoma [PDF]

open access: yes, 2017
Primary aldosteronism (PA), also known as Conn's syndrome, is a frequent cause of secondary hypertension. If PA is due to a documented unilateral adrenal adenoma, adrenalectomy is the treatment of choice.
Bardelli, Moreno   +6 more
core   +1 more source

Secondary hypertension as a cause of treatment resistance

open access: yesBlood Pressure, 2023
In secondary hypertension, elevated blood pressure is caused by a known and/or potentially treatable underlying disease. Although the prevalence of secondary hypertension depends on the patient population and the thoroughness of applied diagnostic ...
Isabella Sudano   +2 more
doaj   +1 more source

Hyperaldosteronism

open access: yes
Leslie SW, Muppidi V, Gupta S.
europepmc   +2 more sources

Targeting Cryptochromes in Chronic Diseases

open access: yesCell Biology International, Volume 49, Issue 12, Page 1579-1590, December 2025.
ABSTRACT The circadian clock generates 24‐h molecular rhythms through transcription–translation negative feedback loops (TTFLs) and regulates daily physiological processes such as sleep–wake cycles, body temperature, hormone secretion, metabolism, and immune function.
Takuro Toda, Tsuyoshi Hirota
wiley   +1 more source

The prevalence of resistant arterial hypertension and secondary causes in a cohort of hypertensive patients: a single center experience [PDF]

open access: yes, 2017
The prevalence of resistant hypertension (RHT) still remains unknown. Aim of the study was to investigate in a large cohort of hypertensive patients the prevalence of RHT, and to identify in these patients the secondary forms of arterial hypertension (SH)
Concistre, Antonio   +13 more
core   +2 more sources

Junctional Bradycardia as Early Sign of Digoxin Toxicity in a Premature Infant with Congestive Heart Failure due to a Left to Right Shunt

open access: yesAmerican Journal of Perinatology Reports, 2016
Introduction Congestive heart failure due to left to right cardiac shunt is usually managed medically with diuretics, angiotensin converting enzyme inhibitors, and, in some cases, with the addition of digoxin.
Soham Dasgupta   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy